Controversial gene therapy tests, and algorithms on trial
Last year, biotech startup Minicircle started recruiting participants for a clinical trial of gene therapy.
For one, it instructed would-be guinea pigs to purchase an NFT to take part, before being paid in cryptocurrency.
Another is it would take place in what is essentially an experimental crypto city—Próspera, Honduras.
It’s against this unusual backdrop that Minicircle is trying to lead biohacking’s charge into the mainstream—studying gene therapies that target familiar conditions like muscular disorders, HIV, low testosterone, and obesity.
Now they’re at the center of a landmark legal case that ultimately has the power to completely change how we live online.